Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - NASDAQ:CROX - US2270461096 - Common Stock

78.43 USD
-1.8 (-2.24%)
Last: 11/6/2025, 5:34:07 PM
78.63 USD
+0.2 (+0.26%)
After Hours: 11/6/2025, 5:34:07 PM
Fundamental Rating

7

Overall CROX gets a fundamental rating of 7 out of 10. We evaluated CROX against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CROX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make CROX a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
In the past 5 years CROX has always been profitable.
Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

The Return On Assets of CROX (4.25%) is better than 64.58% of its industry peers.
CROX has a Return On Equity of 13.39%. This is in the better half of the industry: CROX outperforms 70.83% of its industry peers.
With an excellent Return On Invested Capital value of 23.59%, CROX belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 12.15%.
The 3 year average ROIC (22.59%) for CROX is below the current ROIC(23.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROIC 23.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX has a better Profit Margin (4.48%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
Looking at the Operating Margin, with a value of 23.11%, CROX belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
CROX's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 59.08%, CROX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.74 indicates that CROX is not in any danger for bankruptcy at the moment.
The Altman-Z score of CROX (3.74) is better than 72.92% of its industry peers.
The Debt to FCF ratio of CROX is 1.84, which is an excellent value as it means it would take CROX, only 1.84 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.84, CROX belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
CROX has a worse Debt to Equity ratio (0.97) than 72.92% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Altman-Z 3.74
ROIC/WACC2.1
WACC11.21%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CROX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.40, CROX is not doing good in the industry: 77.08% of the companies in the same industry are doing better.
CROX has a Quick Ratio of 1.40. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
CROX has a worse Quick ratio (0.83) than 68.75% of its industry peers.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.83
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.09%.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.64% yearly.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.01%.
The Revenue has been growing by 27.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%

3.2 Future

Based on estimates for the next years, CROX will show a small growth in Earnings Per Share. The EPS will grow by 2.84% on average per year.
The Revenue is expected to grow by 2.29% on average over the next years.
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.19, which indicates a rather cheap valuation of CROX.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CROX to the average of the S&P500 Index (25.67), we can say CROX is valued rather cheaply.
A Price/Forward Earnings ratio of 6.45 indicates a rather cheap valuation of CROX.
Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 97.92% of the companies are valued more expensively.
CROX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 31.86.
Industry RankSector Rank
PE 6.19
Fwd PE 6.45
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 93.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.98
EV/EBITDA 5.45
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CROX's earnings are expected to decrease with -2.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (11/6/2025, 5:34:07 PM)

After market: 78.63 +0.2 (+0.26%)

78.43

-1.8 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners103.9%
Inst Owner Change-0.71%
Ins Owners2.6%
Ins Owner Change1.77%
Market Cap4.28B
Revenue(TTM)4.07B
Net Income(TTM)182.55M
Analysts73.64
Price Target89.54 (14.17%)
Short Float %13.06%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.3%
Min EPS beat(2)3.5%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)13.09%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.48%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.48%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)-3.83%
PT rev (3m)-29.1%
EPS NQ rev (1m)-0.09%
EPS NQ rev (3m)-27.93%
EPS NY rev (1m)-0.09%
EPS NY rev (3m)-9.63%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)-9.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.95%
Valuation
Industry RankSector Rank
PE 6.19
Fwd PE 6.45
P/S 1.05
P/FCF 5.98
P/OCF 5.49
P/B 3.14
P/tB N/A
EV/EBITDA 5.45
EPS(TTM)12.67
EY16.15%
EPS(NY)12.15
Fwd EY15.5%
FCF(TTM)13.11
FCFY16.72%
OCF(TTM)14.28
OCFY18.2%
SpS74.57
BVpS24.96
TBVpS-6.81
PEG (NY)N/A
PEG (5Y)0.12
Graham Number84.35
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROCE 26.08%
ROIC 23.59%
ROICexc 24.64%
ROICexgc 49.52%
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
FCFM 17.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Debt/EBITDA 1.3
Cap/Depr 83.38%
Cap/Sales 1.56%
Interest Coverage 11.87
Cash Conversion 76.65%
Profit Quality 392.36%
Current Ratio 1.4
Quick Ratio 0.83
Altman-Z 3.74
F-Score6
WACC11.21%
ROIC/WACC2.1
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%
EBIT growth 1Y-11.62%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-9.8%
EBIT Next 3Y-6.47%
EBIT Next 5Y3.43%
FCF growth 1Y-14.34%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-16.78%
OCF growth 3Y20.5%
OCF growth 5Y61.62%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CROX.


What is the valuation status for CROX stock?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CROCS INC (CROX) stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 6.19 and the Price/Book (PB) ratio is 3.14.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 7 / 10.